Analyst Research

Report Title Price
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : GlobalData
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Faes Farma SA Creates Joint-Venture With Laboratorios Senosiain

Monday, 28 Oct 2013 03:40pm EDT 

Faes Farma SA announced that on October 28, 2013 it created in Mexico a joint-venture with Laboratorios Senosiain, called MIT Farma. Under the terms of the agreement, Faes Farma SA will provide its products for their marketing on the Mexican market through the joint-venture, and Laboratorios Senosiain will contribute with its knowledge of the local market. MIT Farma will market the second brand of antihistamine bilastina, and the second brand of hidrosmin, other original products from Faes Farma SA’s portfolio and the products currently under development by Faes Farma SA. 

Company Quote

-0.035 -1.45%
11:35am EDT